Zobrazeno 1 - 10
of 163
pro vyhledávání: '"Manuel González Barón"'
Autor:
Enrique Espinosa, Iker Sánchez-Navarro, Angelo Gámez-Pozo, Alvaro Pinto Marin, David Hardisson, Rosario Madero, Andrés Redondo, Pilar Zamora, Belén San José Valiente, Marta Mendiola, Manuel González Barón, Juan Angel Fresno Vara
Publikováno v:
PLoS ONE, Vol 4, Iss 6, p e5911 (2009)
INTRODUCTION: Gene profiling may improve prognostic accuracy in patients with early breast cancer, but this technology is not widely available. We used commercial assays for qRT-PCR to assess the performance of the gene profiles included in the 70-Ge
Externí odkaz:
https://doaj.org/article/bd6fb78093714c29bc4d6a6a052b1ca5
Autor:
Paloma Cejas, Manuel González-Barón, Damián García-Olmo, Rosa Miquel, Noemí Manceñido, Miguel Ángel García-Cabezas, Emilio Burgos, Benito Sánchez-Llamas, María Sereno, Cristóbal Belda-Iniesta, Beatriz Castelo, Javier de Castro, Carlos Fernández-Martos, Jaime Feliu, Joan Maurel, Montserrat Blanco, Jose Javier Sánchez, Victor Moreno García, Enrique Casado
Supplementary Figures S1-S4; Supplementary Tables S1-S3.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4773e44ffb275dd23b59a518b2df8abd
https://doi.org/10.1158/1078-0432.22441156
https://doi.org/10.1158/1078-0432.22441156
Autor:
Paloma Cejas, Manuel González-Barón, Damián García-Olmo, Rosa Miquel, Noemí Manceñido, Miguel Ángel García-Cabezas, Emilio Burgos, Benito Sánchez-Llamas, María Sereno, Cristóbal Belda-Iniesta, Beatriz Castelo, Javier de Castro, Carlos Fernández-Martos, Jaime Feliu, Joan Maurel, Montserrat Blanco, Jose Javier Sánchez, Victor Moreno García, Enrique Casado
Purpose: Preoperative chemoradiotherapy (CRT) is the treatment of choice for rectal cancer (RC), but half of the patients do not respond, suffer unnecessary toxicities, and surgery delays. We aimed to develop a model that could predict a clinically m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80515b40f5fc218fb3999fe8aeb89045
https://doi.org/10.1158/1078-0432.c.6518296.v1
https://doi.org/10.1158/1078-0432.c.6518296.v1
Autor:
Yves Fouche, Marc Baron, Florent Boutitie, G. Houvenaeghel, Daniel Raudrant, Eric Leblanc, Catherine Uzan, V. Fourchotte, J-M Classe, P. Morice, Anne-Sophie Bats, Fabrice Lecuru, C. Pomel, L. Boulanger, Jean Levêque, G. Mage, Olivier Graesslin, Patrice Mathevet, Frederic Guyon, Emile Daraï, Vanessa Conri, Philippe Descamps, Jean-Jacques Baldauf, Henri Marret, A S Bats, Denis Querleu, Virginie Fourchotte, Laurent Magaud, B. Ott, Serge Douvier, E. Stoeckle, P. Rouanet, P. Mathevet, Manuel González Barón, D. Lanvin, Y. Delpech
Publikováno v:
European Journal of Cancer. 148:307-315
Introduction Pelvic lymph node dissection has been the standard of care for patients with early cervical cancer. Sentinel node (SN) mapping is safe and feasible and may increase the detection of metastatic disease, but benefits of omitting pelvic lym
Autor:
Iker Sánchez-Navarro, Angelo Gámez-Pozo, Manuel González-Barón, Álvaro Pinto-Marín, David Hardisson, Rocío López, Rosario Madero, Paloma Cejas, Marta Mendiola, Enrique Espinosa, Juan Ángel Fresno Vara
Publikováno v:
BioTechniques, Vol 48, Iss 5, Pp 389-397 (2010)
Recent reports demonstrate the feasibility of quantifying gene expression by using RNA isolated from blocks of formalin-fixed, paraffin-embedded (FFPE) tumor tissue. The development of molecular tests for clinical use based on archival materials woul
Externí odkaz:
https://doaj.org/article/138c2e8e23704f81b8d19e2a6cef265f
Autor:
Miguel Ángel García-Cabezas, Juan Carlos Lacal, Joan Maurel, Jose Javier Sanchez, Victor Moreno Garcia, César Gómez-Raposo, Paloma Cejas, Jaime Feliu, Carlos Fernández-Martos, Beatriz Castelo, Juan Moreno Rubio, Emilio Burgos, Javier de Castro, María Teresa Gómez del Pulgar, Enrique Casado, Miriam López-Gómez, Manuel González-Barón, Francisco Zambrana, Cristobal Belda-Iniesta, Pilar Vázquez, María Sereno, Rocío López
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
[Purpose]: Management of locally advanced rectal cancer (RC) consists of neoadjuvant chemoradiotherapy (CRT) with fluoropyrimidines, followed by total mesorectal excision. We sought to evaluate the expression of selected genes, some of which were der
Autor:
Andrés Redondo Sánchez, Enrique Espinosa Arranz, Álvaro Pinto Marín, Beatriz Castelo Fernández, Pilar Zamora Auñón, Manuel González Barón
Publikováno v:
Urologic Oncology: Seminars and Original Investigations. 30:356-361
Renal cell carcinoma therapy has changed in a very significant way in the last few years. Up to 5 new agents have been developed, improving the results previously achieved with cytokine therapy. Bevacizumab, sorafenib, sunitinib, temsirolimus, and ev
Autor:
Cristobal Belda-Iniesta, Juan Moreno-Rubio, Esther Díaz, Emilio Burgos, V. Moreno Garcia, J. de Castro Carpeño, Paloma Cejas, Jorge Barriuso, Manuel González-Barón, J. Feliu, Cristina Aguayo, Miriam López-Gómez, Rosario Madero
Publikováno v:
Current Cancer Drug Targets. 12:124-131
Patients with metastatic Colorectal Cancer (mCRC), in which primary tumors are KRAS mutated, have no response to anti-EGFR therapy. However, less than half of mCRC patients with KRAS wild-type primary tumors respond to anti-EGFR therapy. Other downst
Autor:
Jaime Feliu, Ana María Jimenez-Gordo, Juan Carlos Cámara, Javier de Castro, Alberto Alonso-Babarro, Rosario Madero, José Ramón Rodríguez-Aizcorbe, Enrique Espinosa, Beatriz Martínez, Raquel Molina, Manuel González-Barón, Jesús Domingo Acedo, María Luisa García-Paredes
Publikováno v:
JNCI: Journal of the National Cancer Institute. 103:1613-1620
Background Determining life expectancy in terminally ill cancer patients is a difficult task. We aimed to develop and validate a nomogram to predict the length of survival in patients with terminal disease. Methods From February 1, 2003, to December
Autor:
Miguel Ángel García-Cabezas, Emilio Burgos, Beatriz Castelo, Damián García-Olmo, Paloma Cejas, Montserrat Blanco, Cristobal Belda-Iniesta, Jaime Feliu, Enrique Casado, Jose Javier Sanchez, Benito Sánchez-Llamas, Manuel González-Barón, Rosa Miquel, Carlos Fernández-Martos, Javier de Castro, María Sereno, Victor Moreno Garcia, Joan Maurel, Noemi Mancenido
Publikováno v:
Clinical Cancer Research. 17:4145-4154
Purpose: Preoperative chemoradiotherapy (CRT) is the treatment of choice for rectal cancer (RC), but half of the patients do not respond, suffer unnecessary toxicities, and surgery delays. We aimed to develop a model that could predict a clinically m